← Back to Volume 6, Issue 7

Brain Network and Synaptic Plasticity Changes Associated with Electroconvulsive Therapy for Depression: A Multilevel Review

Yihan Jiang, Xinying Jiang, Yuting Huang, Xiaohui Yu
Vol.6, No.7, pp.1-10, 2026 DOI: 10.62051/ijphmr.v6n7.01 August 28, 2026
Download PDF
Abstract: Electroconvulsive therapy (ECT) is an important treatment for severe, treatment-resistant, or high-risk depression, yet the relationship between its antidepressant effects, brain network changes, and cellular and molecular processes remains incompletely understood. Recent advances in multimodal magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), molecular biology, and animal electroconvulsive stimulation models have provided multilevel evidence for understanding the neurobiological mechanisms of ECT in depression. Current studies suggest that ECT is accompanied by changes in functional connectivity within large-scale brain networks, including the default mode network (DMN), the frontoparietal control network (FPCN), and prefrontal-limbic circuits. In parallel, processes involving neurotransmission, brain metabolism, neurotrophic factors, inflammatory responses, and synaptic plasticity may provide biological clues for interpreting these network-level changes. This review summarizes evidence related to brain network reorganization and synaptic plasticity-associated regulation in ECT for depression, and discusses how findings across levels may be integrated to inform future mechanistic research and treatment-response prediction.
Keywords: ECT, Depression, MRI, Brain network reorganization, Synaptic plasticity
APA Citation: Yihan Jiang, Xinying Jiang, Yuting Huang, Xiaohui Yu (2026). Brain Network and Synaptic Plasticity Changes Associated with Electroconvulsive Therapy for Depression: A Multilevel Review. International Journal of Public Health and Medical Research, 6(7), 1-10. https://doi.org/10.62051/ijphmr.v6n7.01

References

  1. Kirov, G., et al. (2021). Electroconvulsive therapy for depression: 80 years of progress. British Journal of Psychiatry, 219(5), 594–597. https://doi.org/10.1192/bjp.2021.129
  2. Stojanović, Z., et al. (2024). Electroconvulsive therapy in the Fourth Industrial Revolution (Review). Biomedical Reports, 21(3), 129. https://doi.org/10.3892/br.2024.1746
  3. Belge, J. B., et al. (2023). Reviewing the neurobiology of electroconvulsive therapy on a micro-, meso- and macro-level. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 127, 110809. https://doi.org/10.1016/j.pnpbp.2023.110809
  4. Kritzer, M. D., Peterchev, A. V., & Camprodon, J. A. (2023). Electroconvulsive therapy: Mechanisms of action, clinical considerations, and future directions. Harvard Review of Psychiatry, 31(3), 101–113. https://doi.org/10.1097/HRP.0000000000000356
  5. Li, Y., et al. (2023). Neural signatures of default mode network in major depression disorder after electroconvulsive therapy. Cerebral Cortex, 33(7), 3840–3852. https://doi.org/10.1093/cercor/bhad048
  6. Denier, N., et al. (2023). Electroconvulsive therapy induces remodeling of hippocampal co-activation with the default mode network in patients with depression. NeuroImage: Clinical, 38, 103404. https://doi.org/10.1016/j.nicl.2023.103404
  7. Domke, A. K., et al. (2023). Functional connectivity changes between amygdala and prefrontal cortex after ECT are associated with improvement in distinct depressive symptoms. European Archives of Psychiatry and Clinical Neuroscience, 273(7), 1489–1499. https://doi.org/10.1007/s00406-023-01587-9
  8. Gryglewski, G., et al. (2021). Meta-analysis of brain structural changes after electroconvulsive therapy in depression. Brain Stimulation, 14(4), 927–937. https://doi.org/10.1016/j.brs.2021.05.011
  9. Ousdal, O. T., et al. (2020). Brain changes induced by electroconvulsive therapy are broadly distributed. Biological Psychiatry, 87(5), 451–461. https://doi.org/10.1016/j.biopsych.2019.09.019
  10. Janouschek, H., et al. (2021). Meta-analytic evidence for volume increases in the medial temporal lobe after electroconvulsive therapy. Biological Psychiatry, 90(4), e11–e17. https://doi.org/10.1016/j.biopsych.2021.01.015
  11. Qian, R., et al. (2026). Neurobiological mechanisms of electroconvulsive therapy in major depressive disorder: structure-function coupling with gene expression and molecular mechanism. Translational Psychiatry, 16(1), 76. https://doi.org/10.1038/s41398-026-04094-2
  12. De Jager, J. E., et al. (2024). Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression. Neuroscience & Biobehavioral Reviews, 164, 105796. https://doi.org/10.1016/j.neubiorev.2024.105796
  13. Gbyl, K., et al. (2021). Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 104, 110048. https://doi.org/10.1016/j.pnpbp.2020.110048
  14. Mulders, P. C. R., et al. (2020). Structural changes induced by electroconvulsive therapy are associated with clinical outcome. Brain Stimulation, 13(3), 696–704. https://doi.org/10.1016/j.brs.2020.02.013
  15. Abe, Y., et al. (2024). Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation. Neuropsychopharmacology, 49(8), 1236–1245. https://doi.org/10.1038/s41386-024-01780-1
  16. Buckner, R. L., Andrews-Hanna, J. R., & Schacter, D. L. (2008). The brain's default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences, 1124, 1–38. https://doi.org/10.1196/annals.1440.011
  17. Raichle, M. E., et al. (2001). A default mode of brain function. Proceedings of the National Academy of Sciences, 98(2), 676–682. https://doi.org/10.1073/pnas.98.2.676
  18. Vincent, J. L., et al. (2008). Evidence for a frontoparietal control system revealed by intrinsic functional connectivity. Journal of Neurophysiology, 100(6), 3328–3342. https://doi.org/10.1152/jn.90355.2008
  19. Li, Y., et al. (2022). Mapping intrinsic functional network topological architecture in major depression disorder after electroconvulsive therapy. Journal of Affective Disorders, 311, 103–109. https://doi.org/10.1016/j.jad.2022.05.062
  20. Liu, D., et al. (2022). Changes in brain network properties in major depressive disorder following electroconvulsive therapy: a combined static and dynamic functional magnetic resonance imaging study. Annals of Palliative Medicine, 11(6), 1969–1980. https://doi.org/10.21037/apm-22-541
  21. Sun, S., et al. (2022). Electroconvulsive therapy-induced changes in functional brain network of major depressive disorder patients: A longitudinal resting-state electroencephalography study. Frontiers in Human Neuroscience, 16, 852657. https://doi.org/10.3389/fnhum.2022.852657
  22. Appelbaum, L. G., et al. (2023). Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology, 48(1), 113–120. https://doi.org/10.1038/s41386-022-01439-8
  23. Kang, H. J., et al. (2012). Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nature Medicine, 18(9), 1413–1417. https://doi.org/10.1038/nm.2886
  24. Holmes, S. E., et al. (2019). Lower synaptic density is associated with depression severity and network alterations. Nature Communications, 10, 1529. https://doi.org/10.1038/s41467-019-09562-8
  25. Laroy, M., et al. (2025). Synaptic density changes following electroconvulsive therapy: a longitudinal pilot study with PET-MR 11C-UCB-J imaging in late-life depression. Brain Stimulation, 18(1), 267. https://doi.org/10.1016/j.brs.2024.12.008
  26. Bajbouj, M., et al. (2006). Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. Journal of Psychiatric Research, 40(4), 322–327. https://doi.org/10.1016/j.jpsychires.2005.08.003
  27. Voineskos, D., et al. (2016). The relationship between cortical inhibition and electroconvulsive therapy in the treatment of major depressive disorder. Scientific Reports, 6, 37461. https://doi.org/10.1038/srep37461
  28. Casarotto, S., et al. (2013). Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography. Brain Topography, 26(2), 326–337. https://doi.org/10.1007/s10548-012-0254-9
  29. Luscher, B., Shen, Q., & Sahir, N. (2011). The GABAergic deficit hypothesis of major depressive disorder. Molecular Psychiatry, 16(4), 383–406. https://doi.org/10.1038/mp.2010.75
  30. Cano, M., et al. (2017). Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study. Translational Psychiatry, 7(2), e1023. https://doi.org/10.1038/tp.2016.286
  31. Sanacora, G., et al. (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. American Journal of Psychiatry, 160(3), 577–579. https://doi.org/10.1176/appi.ajp.160.3.577
  32. Erchinger, V. J., et al. (2023). Electroconvulsive therapy triggers a reversible decrease in brain N-acetylaspartate. Frontiers in Psychiatry, 14, 1155689. https://doi.org/10.3389/fpsyt.2023.1155689
  33. Puts, N. A., & Edden, R. A. (2012). In vivo magnetic resonance spectroscopy of GABA: a methodological review. Progress in Nuclear Magnetic Resonance Spectroscopy, 60, 29–41. https://doi.org/10.1016/j.pnmrs.2011.11.001
  34. Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learning & Memory, 10(2), 86–98. https://doi.org/10.1101/lm.54603
  35. Nelson, E. D., et al. (2023). Activity-regulated gene expression across cell types of the mouse hippocampus. Hippocampus, 33(9), 1009–1027. https://doi.org/10.1002/hipo.23551
  36. Meyers, K. T., et al. (2018). The immediate early gene Egr3 is required for hippocampal induction of Bdnf by electroconvulsive stimulation. Frontiers in Behavioral Neuroscience, 12, 92. https://doi.org/10.3389/fnbeh.2018.00092
  37. Maynard, K. R., et al. (2018). Electroconvulsive seizures influence dendritic spine morphology and BDNF expression in a neuroendocrine model of depression. Brain Stimulation, 11(4), 856–859. https://doi.org/10.1016/j.brs.2018.04.013
  38. Chen, F., et al. (2009). Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. European Neuropsychopharmacology, 19(5), 329–338. https://doi.org/10.1016/j.euroneuro.2008.12.006
  39. Pelosof, R., et al. (2023). BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis. World Journal of Biological Psychiatry, 24(1), 24–33. https://doi.org/10.1080/15622975.2022.2095847
  40. Brunoni, A. R., et al. (2014). BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis. World Journal of Biological Psychiatry, 15(5), 411–418. https://doi.org/10.3109/15622975.2013.876674
  41. Sorri, A., et al. (2021). Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder. Brain and Behavior, 11(8), e02001. https://doi.org/10.1002/brb3.2001
  42. Polyakova, M., et al. (2015). Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature. PLOS ONE, 10(11), e0141564. https://doi.org/10.1371/journal.pone.0141564
  43. Warner-Schmidt, J. L., & Duman, R. S. (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences, 104(11), 4647–4652. https://doi.org/10.1073/pnas.0610282104
  44. Kruse, J. L., et al. (2018). Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression. Journal of Clinical Psychiatry, 79(2), 17m11597. https://doi.org/10.4088/JCP.17m11597
  45. Belge, J.-B., et al. (2020). Inflammation, Hippocampal Volume, and Therapeutic Outcome following Electroconvulsive Therapy in Depressive Patients: A Pilot Study. Neuropsychobiology, 79(3), 222–232. https://doi.org/10.1159/000506477
  46. Carlier, A., et al. (2019). Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study. Journal of Affective Disorders, 256, 509–516. https://doi.org/10.1016/j.jad.2019.06.047
  47. An, X., & Shi, X. (2020). Effects of electroconvulsive shock on neuro-immune responses: Does neuro-damage occur? Psychiatry Research, 292, 113289. https://doi.org/10.1016/j.psychres.2020.113289
  48. Jorgensen, A., et al. (2016). Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression. Acta Psychiatrica Scandinavica, 133(2), 154–164. https://doi.org/10.1111/acps.12507
  49. Bouckaert, F., et al. (2016). Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression. Neuropsychopharmacology, 41(11), 2741–2748. https://doi.org/10.1038/npp.2016.92
  50. Andreou, B., et al. (2022). Longitudinal trajectory of response to electroconvulsive therapy associated with transient immune response & white matter alteration post-stimulation. Translational Psychiatry, 12(1), 191. https://doi.org/10.1038/s41398-022-01918-1
  51. Sun, H., et al. (2024). Functional connectivity analyses of individual hippocampal subregions in major depressive disorder with electroconvulsive therapy. Psychoradiology, 4, kkae030. https://doi.org/10.1093/psyrad/kkae030
  52. Selvaggi, P., et al. (2021). Integration of human whole-brain transcriptome and neuroimaging data: Practical considerations of current available methods. Journal of Neuroscience Methods, 355, 109128. https://doi.org/10.1016/j.jneumeth.2021.109128
  53. Laroy, M., et al. (2025). Molecular Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging for Understanding the Neurobiological Mechanisms of Electroconvulsive Therapy: A Scoping Review. Journal of ECT, 41(4), 268–280. https://doi.org/10.1097/YECT.0000000000000546